CPS Technologies Corp. (NASDAQ:CPSH) today announced that it has received its first product order from a defense-related customer for tungsten alloy components manufactured using the Company’s proprietary QuickSet Injection Molding™ process. The order, placed by a research group supporting the U.S. military, represents the largest contract of its kind received by the Company to date. Additional details cannot be disclosed due to confidentiality provisions. The continued development of the Company’s QuickSet technology is supported through funding from an ongoing Small Business Technology Transfer (STTR) award, previously disclosed, from the U.S. Army Combat Capabilities Development Command (DEVCOM); the $1.15 million Phase II contract, led by Mark Occhionero, PhD, began in 2025 and is scheduled to continue through September 2027. 

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.